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ABSTRACT  
Introduction Stroke is the most burden complication in a patient with atrial fibrillation. Atrial Fibrillation (AF) is the common cardiac 
arrythmia in stroke patients. The epidemiology study of AF-associated stroke were limited published research in southeast. This study may 
prove valuable in routine clinical practice. This systematic review aimed to identify the latest evidence on the epidemiology of AF related stroke 
in southeast Asia regions. 
Methods: We performed a comprehensive search on prevalence or incidence of atrial fibrillation related stroke from inception up until 
September 2019 through PubMed and Cochrane Central Database. The keywords were the combination of the following words:  “stro ke”, 
“epidemiology”, “atrial fibrillation”, and was then used with the name of each country in southeast Asia”. The inclusion criteria of the study i.e : 
patients with stroke, was a original papers with observational study, concerned on AF in stroke patients in southeast Asia. Data on incidence 
and prevalence were obtained from hospital-based studies and community-based studies.  
Results: Atrial Fibrillation prevalence data are available in five countries in southeast Asia, a total of the 11 articles identified were from 
Malaysia, Thailand, Vietnam, Singapore, and Indonesia were also represented. The reported prevalence of AF as a risk factor of stroke patients 
was 2.6 % until 23.04% based on hospital-based studies. 
Conclusion: AF is one of risk factors that associated with the stroke. This study also showed that prevalence AF in South East Asia ranged  2.6 – 
23.04 % . However, owing to the limited number of studies in southeast Asian countries, further investigation is needed before drawing a 
definite true of prevalence of AF in the southeast Asia population. 
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1.  INTRODUCTION 
Atrial Fibrillation (AF) is the most powerful cardiac 
arrhythmia associated with stroke.1 Stroke is the most 
burden complication in a patient with atrial fibrillation.  
Cardioembolic stroke is a stroke that be caused by AF.2 The 
mortality of Cardioembolic stroke reaches 20% and 
Disability approximately 60%.3 Cardioembolic stroke is most 
common in the elderly, especially the oldest-old AF patients. 
Atrial fibrillation (AF) increases 4–5-fold the risk factor for 
stroke than that in patients without AF.4 
The prevalence of AF is growing worldwide with advances in 
technology, higher prediction methods and increased 
awareness among healthcare professionals and patients. It is 
estimated that in the year 2050 Asian population with AF 
will get through 72 million and of whom 2.9 million AF may 
associate with stroke.5, 6 Thus, prevalence and incidence of 
AF is important to know as a troubled healthcare and public-
health concern in Asia.  
The epidemiology study of AF-associated stroke has been 
widely investigated worldwide however there were few 
published research about prevalence AF in stroke patients, 
especially from southeast Asia countries. These gaps in the 
study of prevalence stroke patients with AF probable lead to 
sub-optimal treatments of patients with AF in stroke 
patients. Due to a lack of systematic data in many countries 
in the southeast Asia region, we review the incidence and 
prevalence of AF related-stroke patients from southeast Asia. 
The aim of this study was to report a systematic review of 
the published literature on the epidemiology of AF related 
stroke in southeast Asia regions.  
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2.  METHODS 
We performed a comprehensive search on prevalence or 
incidence of atrial fibrillation in stroke from inception up 
until September 2019 through PubMed and Cochrane Central 
Database. The keywords used were: “stroke”, 
“epidemiology”, “atrial fibrillation” was then used with the 
name of each country in southeast Asia. The records were 
then systematically evaluated using inclusion and exclusion 
criteria. The inclusion criteria of the study i.e.: patients with 
stroke, was a original papers with observational study, 
concerned on AF in stroke patients in southeast Asia. Data on 
incidence and prevalence were obtained from hospital-based 
studies and community-based studies with wide age ranges 
and no upper limit. All the data search was conducted by a 
single author (RP). We include all related clinical 
researches/original articles including conference 
proceedings, and exclude case reports, review articles, and 
non-English language articles. The data were then tabulated, 
stratified according to geographical regions. Preferred 
Reporting Items for Systematic Reviews flowchart of the 
literature search strategy of studies investigating the 
ablation index was presented in Fig. 1. This report presents a 
descriptive analysis of the data and no meta-analysis was 
planned.
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flow diagram 
 
3.  RESULTS AND DISCUSSION: 
Table 1 Characteristics of the observational studies on stroke 
Research site First author 
(Publication year) 
Sex Age Type of 
stroke 
Sample Sample who 
had a Atrial 
Fibrillation 
Hospital-based studies 
 Indonesia 
 
 Misbach J (2001)  Male>female 58.8± 13.3 
(18–95) 
ischemic & 
hemorrhagic 
2065 5.8%7 
 Indonesia  Pinzon  R(2019) Male > Female >60 (82,22%) Ischemic 1688 2.62%8 
 Malaysia 
  
 Aziz ZA(2016)   Male>female 
(55.1vs44.9) 
67.9 ±13.3 ischemic  4762 
 
6.5%9 
 
 Malaysia  Chee KH (2014) Male >female 71.0 ± 2.2 
(43 - 86 ) 
Ischemic 207 10.6%10 
 Malaysia  Hwong WY(2017) Male > female 
(55 vs45) 
.>60(57%) Ischemic 5292 7%11 
 Malaysia  Aziz ZA (2015) Male >female  62.7 ± 12.5 ischemic & 
hemorrhagic 
7830 2.6%12 
 Thailand  Phrommintikul A 
(2016) 
Male &female   73.2 ± 6 ischemic & 
hemorrhagic 
14 16.7%13 
 Thailand  Vorasoot N (2019) Male >female >18 years Ischemic 768 23.04%14 
 Vietnam  Yamanashi Hirotomo A 
(2012) 
Male>female 
(61.1vs38.9) 
65.0 ±14.8 ischemic & 
hemorrhagic 
754 5.8%15 
 Singapore  Sharma VK (2012) Male & Female 64.1 ± 11.9 ischemic & 
hemorrhagic 
481 10%16sin 
Community-based studies 
 Thailand  Kannikar Kongbunkiat 
(2015) 
Male & Female >18 years Ischemic 277.291 9.1%17 
 
101 of record identified 
through database searching 
0 of additional records identified 
through other sources 
52 of records after 
duplicated removed 
52 of records screened 
11 of full text article 
assessed for eligibility 
39 of records excluded 
2 of no full text article 
assessed for eligibility 
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Atrial Fibrillation prevalence data are available in five 
countries in southeast Asia, a total of the 11 articles 
identified were from Malaysia, Thailand, Vietnam, Singapore, 
and Indonesia were also represented. The reported 
prevalence of AF as a risk factor of stroke patients was 2.6 % 
until 23.04% based on hospital-based studies.  The rate of 
stroke-related to AF was similar a systematic review from 
eight countries in Asia, which was 0.36% to 28.3% in 
hospital-based studies18. A systematic review of the 
epidemiology of atrial fibrillation in regions outside North 
America and Europe reported that nearly similar prevalence 
of AF in stroke showed 2.8% to 14%.19 
In Review Hospital-Based studies, Thailand becomes a 
highest of the prevalence of AF in stroke patients and the 
lowest prevalence is seen in Indonesia and Malaysia. In 
Thailand, study Vorasoot N (2019) in similarly with the 
previous epidemiology study that Approximately 20% of all 
ischaemic stroke had AF, however, the inclusion criteria 
included adult patients diagnosed with acute ischemic stroke 
who received rt-PA treatment. In this review, the subject 
predominantly male and mean of age more than 60 years old. 
A similarly previous study that prevalence of AF is higher in 
men and older age1. The mean age was around 70 years19. AF 
patients with AF were aged 60 years or older in most studies 
ranged 57%–98%   Men were more common to develop AF 
than women with 4.4%–7.9%20 
The community-based studies data were screened to find out 
the burden of AF in southeast Asia. The Number of 
community-based studies of only one country is available in 
Thailand. In this review, Kannikar reported that 9% of 
277291 stroke patients related to AF based on community 
studies. Guo Y et al in their systematic review include studies 
in China, Japan, and Singapore, reported that the rate of 
stroke-related to AF was 13.0%–15.4%.  A Systematic 
Review in Asia revealed different the rate of stroke-related to 
AF, which was 1.9% to 6.0%18 In contract, a systematic 
review of in regions outside North America and Europe 
reported that prevalence of AF in stroke with different 
ranges in community-based studies ranged 0.1%to 4%.19 
The variation differences results of prevalence of AF in 
countries were caused variable and the studies were 
performed at different time points, differences in the risk-
factor prevalence, screening/detection method and level of 
control. Thus are not strictly comparable of studies. Mostly in 
review, AF was diagnosed if there was a previous history of 
AF or if it was discovered on electrocardiography (ECG) 
during admission. 
Asian cohorts from the recent randomized trials of the 
NOACs have reported the prevalence of AF-related stroke in 
a RE-LY trial, ROCKET-AF trial and ARISTOTLE trial revealed 
a higher absolute annual rate of ischemic stroke in Asians 
compared with non-Asians.212223 This Result of RCT showed 
that the burden of AF had a great impact on risk in the Asian 
population and The higher prevalence AF related stroke 
become a sign of under treatment of management of AF for 
prevention stroke become a problem seriously in Asian 
populations. these data add support to the view that the 
prevalence of AF in Asian populations is higher than that in 
Western populations.   
Prevalence of AF might be underestimated in developing 
countries and developed countries although the clinical 
burden of AF had a higher risk of stroke events and 
recurrent.  Furthermore, in response to the increasing 
prevalence of AF especially in Asian, additional resources 
will need to be allocated globally for prevention and 
treatment of AF and its associated complications25 Hence, the 
development of tools and strategies to detect AF early should 
be made a priority among clinicians and healthcare 
policymakers. 
AF is often asymptomatic and undetected in older people, so 
if screening for unknown AF has carried buat at scale, and 
people found were treated with an oral anticoagulant, many 
strokes could be prevented. Meta-analysis and systematic 
review fo screening studies for AF by lowres et al have 
shown that unknown AF increased dramatically with age and 
is more common in males.26 Over the age of 55, the detection 
rate is 1.4% on a single timepoint screen with either pulse 
taking or ECG, but for the age group between 80 to 84, it is 
1.9%. The combination of screening detection rate and risk 
of stroke over the age of 65 has led a number of continental 
and country-specific guidelines to recommend screening in 
patients over that age, but this is not practiced worldwide. 
In this hospital-based study in southeast Asia, the study 
collected information only a single ECG recording and did not 
use intermittent ECG or Holter monitoring for screening the 
paroxysmal /silent AF. As a result, AF may be 
underestimated and missed diagnosed in southeast Asia 
countries that had an impact on the outcome in a developing 
country. Some previous studied demonstrated that AF 
contributed to worse outcomes in stroke patients compared 
to stroke patients without AF.1,10  It was necessary to 
recognize AF in stroke patients for improving outcomes in 
Developing Countries. Hospital-based study about AF related 
stroke had a small sample size. Few Sample may contribute 
to the limited power to detect the true prevalence in a 
population. However, owing to the limited number of studies 
in southeast Asian countries, further investigation is needed 
before drawing a definite true of prevalence of AF in 
southeast Asia. 
The methods of single timepoint screening vary form 
physical examination using pulse palpation or auscultation of 
the heart or knockoff sounds while measuring blood 
pressure, to a handheld ECG single lead rhythm strip and 
conventional ECG.5 Single time point screening will largely 
detect persistent or very high burden paroxysmal AF, and 
will, therefore, miss a lot of paroxysmal AF. 26 Causing 
underestimation of unknown AF to overcome this issue, a 
number of more intense screening protocols have been 
adopted. Prolongation of continuous Holter monitoring in 
patients with a cerebral ischemic event increases the rate of 
detection of paroxysmal atrial fibrillation and results in a 
change in therapy in a substantial number of patients. 26 
There are now many devices available to both physicians and 
the general population which can screen for AF from 
photoplethysmographic (PPG) devices in smartphones, 
smart watches and fitness trackers and rings.1,5 They can 
also be used semi-continuously and may, therefore, detect AF 
with low risk, as with implanted devices, so we will need to 
much greater attention to the health impact of what is now 
being promoted to consumers. In Community, teaching a 
high risk population to learn pulse palpation for self-
detection of AF has been shown to be  effective,27 
4.  CONCLUSIONS: 
Prevalence of AF in Stroke patients among southeast Asia 
was ranged from 2.6 % to 23.04%. AF is the most powerful 
risk factor associated with a stroke in which AF prevalence in 
Southeast and  Better detection of AF diagnostic in stroke 
patients is important for preventing recurrent stroke. 
However, owing to the limited number of studies in 
southeast Asian countries, further investigation is needed 
before drawing a definite true of prevalence of AF in the 
southeast Asia population. 
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